HyTdb

H7

HyT-009 | Adamantane | Published 2025.08.14

Basic Information

A3
Linker
Adamantane
POIEML4-ALK — Tyrosine-protein kinase receptor(EML4-ALK)
Degradation PathwayUbiquitin-Proteasome Pathway
Published2025.08.14

Remarks

Chemical Identifiers

SMILESCC(C1=C2)(C)C3=C(C4=C(C=C(C#N)C=C4)N3)C(C1=CC(CC)=C2N5CCN(CC5)CCCC(NC67C[C@H]8C[C@H](C[C@@H](C7)C8)C6)=O)=O
Molecular FormulaC39H47N5O2
InChIInChI=1S/C39H47N5O2/c1-4-28-18-30-31(38(2,3)37-35(36(30)46)29-8-7-24(23-40)17-32(29)41-37)19-33(28)44-12-10-43(11-13-44)9-5-6-34(45)42-39-20-25-14-26(21-39)16-27(15-25)22-39/h7-8,17-19,25-27,41H,4-6,9-16,20-22H2,1-3H3,(H,42,45)/t25-,26+,27-,39?
InChI KeyZNOCTPYIAFNTAL-UWZSUSAUSA-N
IUPAC NameNA
PubChem CIDNA

Basic Properties

TPSAComputing…
RingsComputing…
FSP3Computing…
Heavy Atom CountComputing…

Lipinski RO5

RO5 ViolationComputing…
MWComputing…
ClogPComputing…
HBDComputing…
HBAComputing…
RBComputing…

Hydrophobic Tag Properties

Tag Structure
Tag TypeAdamantane
Tag SMILESC1(CC(C2)C3)CC2CC3C1
Tag ClogP5.022
HydrophobicityHigh (ClogP > 5)

Mechanism of Action

POI (Protein of Interest)

POI NameTyrosine-protein kinase receptor(EML4-ALK)
GeneEML4-ALK
UniProt IDJ7MA22

Amino Acid Sequence

MDGFAGSLDDSISAASTSDVQDRLSALESRVQQQEDEITVLKAALADVLRRLAISEDHVASVKKSVSSKGQPSPRAVIPMSCITNGSGANRKPSHTSAVSIAGKETLSSAAKSGTEKKKEKPQGQREKKEESHSNDQSPQIRASPSPQPSSQPLQIHRQTPESKNATPTKSIKRPSPAEKSHNSWENSDDSRNKLSKIPSTPKLIPKVTKTADKHKDVIINQEGEYIKMFMRGRPITMFIPSDVDNYDDIRTELPPEKLKLEWAYGYRGKDCRANVYLLPTGEIVYFIASVVVLFNYEERTQRHYLGHTDCVKCLAIHPDKIRIATGQIAGVDKDGRPLQPHVRVWDSVTLSTLQIIGLGTFERGVGCLDFSKADSGVHLCVIDDSNEHMLTVWDWQRKAKGAEIKTTNEVVLAVEFHPTDANTIITCGKSHIFFWTWSGNSLTRKQGIFGKYEKPKFVQCLAFLGNGDVLTGDSGGVMLIWSKTTVEPTPGKGPKGVYQISKQIKAHDGSVFTLCQMRNGMLLTGGGKDRKIILWDHDLNPEREIEFSASRARLPGHVAADHPPAVYRRKHQELQAMQMELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEKVPVRPKDPEGVPPLLVSQQAKREEERSPAAPPPLPTTSSGKAAKKPTAAEISVRVPRGPAVEGGHVNMAFSQSNPPSELHKVHGSRNKPTSLWNPTYGSWFTEKPTKKNNPIAKKEPHDRGNLGLEGSCTVPPNVATGRLPGASLLLEPSSLTANMKEVPLFRLRHFPCGNVNYGYQQQGLPLEAATAPGAGHYEDTILKSKNSMNQPGP

3D Structure (/structures/AF-J7MA22-F1-model_v6.cif)

Loading /structures/AF-J7MA22-F1-model_v6.cif …

Function

Essential for the formation and stability of microtubules . Required for the organization of the mitotic spindle and for the proper attachment of kinetochores to MTs. Promotes the recruitment of NUDC to the mitotic spindle for mitotic progression.

Degradation Pathway

NameUbiquitin-Proteasome Pathway
Assay MethodWB,Co-IP

Mechanism

The ubiquitin-proteasome pathway (UPP) constitutes the principal pathway for protein degradation in eukaryotic cells, mediating the breakdown of target proteins through ubiquitin tagging and subsequent proteasomal degradation. In an ATP-dependent manner, the ubiquitin-activating enzyme (E1) activates ubiquitin (Ub) and conjugates it to a ubiquitin-conjugating enzyme (E2). E3 ligase subsequently catalyzes the transfer of Ub to the target protein, leading to the formation of a polyubiquitin chain that completes the ubiquitination mark. The 19S regulatory particle of the 26S proteasome recognizes this ubiquitination signal and, after deubiquitination, mediates the ATP-dependent delivery of the substrate into the 20S proteasome for degradation.

Description

To further elucidate the degradation mechanism, we investigated the involvement of protein degradation pathways. The proteasome inhibitor MG-132 markedly impaired H7-induced ALK degradation, suggesting that the proteasome plays a crucial role in this process (Fig. 6B). HyT promotes protein degradation by mimicking the characteristics of mis folded proteins, thereby triggering recognition and clearance by the cellular quality control machinery [31]. Therefore, we performed co- immunoprecipitation (co-IP) experiments to investigate whether Hsp70 is involved in the action. Co-IP analysis revealed increased binding between ALK and Hsp70, as well as ubiquitin after treatment with H7 for 24 h, suggesting that the engagement of Hsp70 and ubiquitin is essential for the H7-induced degradation of ALK (Fig. 6C). These results collectively indicated that the ubiquitin-proteasome system (UPS), with Hsp70 participation, is responsible for the ALK degradation induced by H7.

Activity Data

TypeDC50
Value0.13±0.01 μM
POI NameEML4-ALK
Cell LineH3122
Cell Line IDCVCL_5160
Assay MethodWB
Reference10.1016/j.bioorg.2025.108876

Description

Since compound H7 demonstrated superior degradation efficiency against EML4-ALK, H3122 cells were selected for further studies. Compound H7 exhibited a concentration-dependent ability to degrade EML4-ALK in H3122 cells, with complete degradation observed and a DC50 of 0.13 ±0.01 μM

TypeIC50
Value0.23 ± 0.03 μM
POI NameEML4-ALK
Cell LineH3122
Cell Line IDCVCL_5160
Assay MethodMTT assays
Reference10.1016/j.bioorg.2025.108876

Description

Compound H7 exhibited superior anti-proliferation activity in H3122 cells, with IC 50 of 0.23 ± 0.03 μM.

Disease Information

DiseaseICD-11Source
lung adenocarcinoma2C25.0Cell Line Origin
HemimegalencephalyLA05.1Gene-Disease Association
Familial benign macrocephalyLB70.3Gene-Disease Association
Overgrowth SyndromeLD2CGene-Disease Association
Hydrocephalus8D64.ZGene-Disease Association